InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,352.96
(
-0.02%
)
US TECH 100
18,567.20
(
0.17%
)
Dow Jones
38,886.17
(
0.00%
)
Brent Oil
80.22
(
0.42%
)
Bitcoin
71,758.13
(
1.40%
)
Post# of 36563
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

alabama1man

Send PM Follow Ignore
Followers 2
Posts 304
Boards Moderated 0
Alias Born 03/27/2018

alabama1man

Re: Obtuse Eye post# 27429

Wednesday, 07/14/2021 5:28:44 PM

Wednesday, July 14, 2021 5:28:44 PM

Post# of 36563
not to mention Merck's therapeutic that seems to be going through a trial in India pretty dern quick (dare I say lickity-split)
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
InvestorsHub NewsWire

Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • MSRM • Jun 5, 2024 1:32 PM

Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology • HYDI • Jun 5, 2024 10:24 AM

Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • HLYK • Jun 5, 2024 8:00 AM

Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers • AVAI • Jun 5, 2024 8:00 AM

IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM

ECGI Holdings Accelerates Strategic Initiatives by Securing First of Two $125,000 Convertible Notes • ECGI • Jun 4, 2024 12:15 PM

Start posting your company's news
Only $200 per official company press release!